RACHEL ONORATO: Open Payments
NPI 1750810834 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 59 payments from 18 companies in 2025. Trend: 2023 $1,591 · 2024 $1,305 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $184 |
| Novo Nordisk Inc | 12 | $156 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Azurity Pharmaceuticals, Inc. | 3 | $51 |
| Seqirus USA Inc | 3 | $50 |
| Avvisto Therapeutics, LLC | 2 | $38 |
| Dexcom, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $35 |
| Renalytix AI, Inc. | 2 | $32 |
Products named: VRAYLAR, Wegovy, UBRELVY, AZMIRO, CYCLOSET, Dexcom G6 Transmitter, JARDIANCE, Flucelvax.
Industry payments across TX — which companies pay providers there.
